What is the recommended diagnostic work‑up and pharmacologic treatment for orthostatic tremor?

Orthostatic Tremor: Diagnostic Work-Up and Pharmacologic Treatment

For orthostatic tremor, confirm the diagnosis with surface EMG showing 13-18 Hz tremor while standing, then initiate gabapentin as first-line therapy, with clonazepam as an alternative if gabapentin fails or is not tolerated.

Diagnostic Work-Up

Clinical Recognition

• Suspect orthostatic tremor in any patient—particularly women over age 50—presenting with progressive leg unsteadiness, tremulousness, or a sensation of "shaky legs" that occurs specifically while standing and is immediately relieved by sitting, leaning, or walking 1, 2.
• The mean age at onset is 59 years (range 13-85), with a female predominance of 64% 1.
• Diagnosis is frequently delayed by an average of 7.2 years because symptoms are often misattributed to anxiety, peripheral neuropathy, or orthostatic hypotension 1.

Essential Diagnostic Criteria

• The pathognomonic finding is a 13-18 Hz tremor detected on surface EMG of the leg muscles during standing; this high-frequency tremor distinguishes orthostatic tremor from all other movement disorders 1, 3, 4.
• The tremor frequency averages 15.7 Hz (range 12.5-20 Hz) and transmits to the arms during weight-bearing in 95.5% of cases 1.
• Perform surface EMG with the patient standing; the tremor will be absent or markedly reduced when sitting or lying down 1, 4.

History and Physical Examination

• Document the specific positional nature of symptoms: patients report leg tremor, unsteadiness, or a feeling of imminent collapse that begins within seconds of standing and resolves immediately upon sitting or walking 1, 2.
• Ask about falls (reported in 24% of patients) and functional impairment in daily activities 1.
• Examine for coexistent neurologic disorders: essential tremor coexists in 23% of cases, parkinsonism in 9%, and mild postural hand tremor is common 1, 2.
• Obtain a family history of tremor (present in 51% of cases) and specifically of orthostatic tremor (present in only 5-7% of cases) 1, 2.

Ancillary Testing

• Surface EMG is the only ancillary test required to confirm the diagnosis; it should show bilateral, synchronous 13-18 Hz tremor in the leg muscles during standing 1, 3, 4.
• No routine laboratory tests, neuroimaging, or autonomic testing are indicated unless there are atypical features suggesting an alternative or secondary cause 4.
• Consider DaTscan or other imaging only if parkinsonism is suspected, as orthostatic tremor can coexist with Parkinson's disease or dementia with Lewy bodies in rare cases 2.

Differential Diagnosis

• Distinguish orthostatic tremor from orthostatic hypotension by measuring blood pressure during standing; orthostatic hypotension shows a systolic drop ≥20 mmHg or diastolic drop ≥10 mmHg within 3 minutes, whereas orthostatic tremor has normal orthostatic vital signs 5.
• Differentiate from POTS by checking heart rate response; POTS shows a sustained heart rate increase ≥30 bpm in adults (≥40 bpm in adolescents) upon standing, which is absent in orthostatic tremor 6.
• Rule out essential tremor (which occurs with action and posture, not specifically standing), peripheral neuropathy (which causes numbness and weakness rather than tremor), and anxiety (which lacks the pathognomonic EMG findings) 4.

Pharmacologic Treatment

First-Line Therapy: Gabapentin

• Initiate gabapentin as the first-line pharmacologic treatment, as it has the most robust evidence for efficacy in orthostatic tremor 7, 8.
• Start at 300 mg once daily and titrate upward by 300 mg every 3-7 days to a target dose of 900-3600 mg/day divided into three doses, based on symptom response and tolerability 7.
• Gabapentin showed the highest efficacy in systematic reviews of prospective cohorts and randomized controlled trials 7.
• Common side effects include sedation, dizziness, and peripheral edema; dose reduction may be necessary in elderly patients or those with renal impairment 7.

Second-Line Therapy: Clonazepam

• If gabapentin is ineffective or not tolerated, switch to clonazepam, which provided at least mild benefit in 56% of patients and moderate-to-marked benefit in 32% 1, 8.
• Start clonazepam at 0.25-0.5 mg at bedtime and increase gradually to 0.5-2 mg/day divided into 2-3 doses 1, 8.
• Clonazepam is the most effective benzodiazepine for orthostatic tremor and showed the highest efficacy in literature reviews 1, 8.
• Monitor for sedation, cognitive impairment, and fall risk, particularly in elderly patients; avoid abrupt discontinuation due to withdrawal risk 8.

Third-Line Options

• Perampanel (an AMPA receptor antagonist) showed high efficacy in a Dutch cohort but also had the highest rate of adverse effects, including dizziness, somnolence, and irritability 8.
• Start perampanel at 2 mg once daily at bedtime and titrate by 2 mg every 1-2 weeks to a maximum of 8-12 mg/day based on response 8.
• Beta-blockers (e.g., propranolol) provided mild benefit in 31% of patients but are generally less effective than gabapentin or clonazepam 1.
• Levodopa showed positive outcomes in some studies but lacks robust evidence and is not routinely recommended 7.

Ineffective or Unproven Therapies

• Levetiracetam and botulinum toxin lack evidence of efficacy for primary orthostatic tremor and should not be used 7.
• Of 46 medications trialed in the largest case series, 24 provided no benefit whatsoever 1.
• Medication benefit often wanes over time, requiring dose adjustments or switching to alternative agents 1.

Surgical Treatment for Refractory Cases

Deep Brain Stimulation (DBS)

• Bilateral ventral intermediate nucleus (VIM) thalamic DBS is effective for medication-refractory orthostatic tremor and should be considered when pharmacologic therapy fails 1, 3, 8.
• DBS was effective in the majority of reported cases, with tremor reduction and improved quality of life, without a higher prevalence of adverse effects compared to medical therapy 8.
• Refer patients with disabling symptoms despite optimal medical management to a movement disorders center with DBS expertise 3, 8.

Common Pitfalls

• Do not diagnose orthostatic tremor based on symptoms alone; surface EMG confirmation of 13-18 Hz tremor is mandatory 1, 4.
• Do not confuse orthostatic tremor with orthostatic hypotension or POTS; measure orthostatic vital signs to exclude these conditions 6, 5.
• Do not overlook coexistent essential tremor or parkinsonism, which occur in 23% and 9% of cases, respectively, and may require additional treatment 1, 2.
• Do not expect complete tremor resolution with medication; treatment goals are symptom reduction and improved function, not cure 1, 8.
• Do not continue ineffective medications indefinitely; if a trial of gabapentin or clonazepam at therapeutic doses for 4-6 weeks shows no benefit, switch to an alternative agent or refer for DBS evaluation 1, 8.